Skip to main content
Clinical Trials/NCT02721147
NCT02721147CompletedNot Applicable

Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast Cancer

Fox Chase Cancer Center1 site in 1 country89 target enrollmentStarted: October 27, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
89
Locations
1
Primary Endpoint
Feasibility of the Treatment as Measured Through Study Accrual

Study Overview

Brief Summary

The central goal of this study is to examine the feasibility, acceptability, and preliminary efficacy of the IE intervention on patient and partner sexual QOL and relationship outcomes, and on patient psychosocial outcomes. We expect that the IE will show adequate feasibility, acceptability, and preliminary efficacy. Secondarily, based on the rationale that barriers exist that limit participation in intensive sexual QOL interventions for breast cancer survivors, an innovative secondary aim will investigate the perspectives of study-eligible patient candidates who opt out of participating in the pilot trial. We expect that we will be able to identify the participation barriers and intervention preferences of breast cancer survivors with sexual concerns who opt out of the intensive trial in order to inform the development of different interventions for future study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age > 21 years
  • •Has diagnosis of non-recurrent stage I-III breast cancer
  • •Completed active treatment (e.g., chemotherapy, radiation therapy, surgery) 6 months-5 years ago (current use of endocrine therapy is acceptable)
  • •Has a partner or spouse who is > 21
  • •Lives with a romantic partner > 6 months
  • •Score of > 3 on Patient Care Monitor Sexual Concerns screening item
  • •No hearing impairment in patient or partner

Exclusion Criteria

  • •Not able to speak English, as stated in medical record or as observed by study team member
  • •ECOG Performance score > 2 OR too ill to participate as judged by physician/in medical record
  • •Overt cognitive dysfunction or psychiatric disturbance such as suicidal ideation or severe mental illness, as observed or judged by the researcher, referring source, or other qualified observer.
  • •Past history of any cancer other than non-melanoma skin cancer
  • •Currently participating in couple/marital therapy
  • •Currently pregnant

Arms & Interventions

Intimacy Enhancing Intervention

Experimental

Participants attend 4 intimacy enhancement intervention sessions over 75 minutes every other week for 4 weeks. The intimacy enhancement intervention comprises 4 main sessions: understanding impact of breast cancer on sex and intimacy, communication about sex/intimacy, problem-solving and changing thoughts, and planning ahead and preparing for challenges. Participants are encouraged to participate in written and behavioral activities at home.

Intervention: Intimacy Enhancing Intervention (Behavioral)

Intimacy Enhancing Intervention

Experimental

Participants attend 4 intimacy enhancement intervention sessions over 75 minutes every other week for 4 weeks. The intimacy enhancement intervention comprises 4 main sessions: understanding impact of breast cancer on sex and intimacy, communication about sex/intimacy, problem-solving and changing thoughts, and planning ahead and preparing for challenges. Participants are encouraged to participate in written and behavioral activities at home.

Intervention: Partner-Assisted Coping Skills Training (Behavioral)

Living Healthy Together

Active Comparator

Participants receive educational information and support about breast cancer every other week for 4 weeks. The educational information and support comprises topics about breast cancer, its treatments, sleep, energy, stress, stress management, nutrition, and diet. Participants are encouraged to read educational materials.

Intervention: Living Healthy Together (Behavioral)

Living Healthy Together

Active Comparator

Participants receive educational information and support about breast cancer every other week for 4 weeks. The educational information and support comprises topics about breast cancer, its treatments, sleep, energy, stress, stress management, nutrition, and diet. Participants are encouraged to read educational materials.

Intervention: Behavioral, Psychological or Informational Intervention (Behavioral)

Outcomes

Primary Outcomes

Feasibility of the Treatment as Measured Through Study Accrual

Time Frame: Up to 8 weeks

Feasibility is measured through the percentage of study eligible individuals who enrolled in the intervention study (i.e., acceptance rate).

Feasibility of the Treatment as Measured Through Study Attrition

Time Frame: Up to 8 weeks

Feasibility of treatment is measured through the number of randomized participants who completed the study.

Feasibility of the Treatment as Measured Through Session Completion by Participant

Time Frame: Up to 8 weeks

Feasibility of the treatment as measured through number of randomized participants who completed all 4 telephone sessions.

Acceptability Measured Using the Client Satisfaction Questionnaire (CSQ-8)

Time Frame: Up to 8 weeks

Acceptability was measured through the median score on a validated acceptability measure. Item responses run on a scale of 1 to 4, with a total score range of 8-32. Higher scores indicate higher satisfaction with the service (acceptability). A median score of 28 or higher is considered acceptable. This measure was collected for both patients and partners.

Secondary Outcomes

  • Change in Depression Measured Using the Patient Health Questionnaire-9 Item(Baseline to up to 8 weeks)
  • Change in Sexual Function Measured Using the Female Sexual Function Index (FSFI)(Baseline to up to 8 weeks)
  • Change in Sexual Function Measured Using the International Index of Erectile Function(Baseline to up to 8 weeks)
  • Change in Sexual Satisfaction Measured Using the Patient-Reported-Outcomes Measurement Information System (PROMIS) Sexual Satisfaction Items(Baseline to up to 8 weeks)
  • Change in Sexual Distress Measured Using the Female Sexual Distress Scale-Revised(Baseline to up to 8 weeks)
  • Change in Beliefs (Self-efficacy)(Baseline to up to 8 weeks)
  • Change in Sexual Communication Measured Using the Dyadic Sexual Communication Scale(Baseline to up to 8 weeks)
  • Change in Relationship Quality Measured Using the Dyadic Adjustment Scale-7 Item(Baseline to up to 8 weeks)
  • Change in Body Image Distress Measured Using the Body Image Scale(Baseline to up to 8 weeks)
  • Change in Emotional Intimacy Measured Using the Personal Assessment of Intimacy in Relationships (PAIR) Emotional Intimacy Scale(Baseline to up to 8 weeks)
  • Change in Anxiety Measured Using the Generalized Anxiety Disorder 7-item(Baseline to up to 8 weeks)
  • Change in Cancer-related Distress Using the Impact of Events Scale-Revised(Baseline to up to 8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials